The problem of pancreatic fistula development after pancreatic surgery in oncological patients

Abstract

Pancreaticoduodenal and distal resections are crucial components of pancreatic cancer treatment. Pancreatic fistula is one of the most common complications of these surgeries. The main criterion for the diagnosis of pancreatic fistula is the increase of amylase drain level more than 3 times from the normal blood level. Pancreatic fistulas worsen the long-term results of cancer treatment and increase the risk of bleeding per an erosion of visceral vessels, pancreatitis and peritonitis, as well as increase the duration of hospital stay. Risk factors for pancreatic fistula can be split in two categories: patient-related and procedure-related. The patient-related risk factors are: male sex, age more than 70 years, small or large diameter of the pancreatic duct, epithelial type of the malignancy, comorbidities and a high volume of drainage fluid in the postoperative period. Surgical risk factors are: the severity of intraoperative blood loss, “soft” pancreas, duration of surgery and surgical techniques.

The most effective method for fistula prophylaxis is intraoperative risk evaluation with initial pancreatectomy in case of high risk. At the same time, it is possible to use medical glues and pharmacological methods for prevention and treatment of postoperative pancreatic fistulas, but further investigations are required. Thus, prevention and treatment of postoperative pancreatic fistulas is a crucial component of management of patients who undergo surgery for pancreatic malignancies.

Keywords

pancreatic neoplasms / pancreaticoduodenal resection / distal pancreatic resection / pancreatic fistula

References

[1] Kaprin AD, Starinskii VV, Shakhzadova AO, editors. State of oncological care for the Russian population in 2021. Moscow: P.A. Herzen MNIOI — branch of FGBU NMC Radiology of the Ministry of Health of Russia; 2022. (In Russ).

[2] Состояние онкологической помощи населению России в 2021 году / под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. Москва : МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022.

[3] Lucas AL, Malvezzi M, Carioli G, et al. Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017. Clinical Gastroenterology and Hepatology. 2016;14(10). doi: 10.1016/j.cgh.2016.05.034

[4] Lucas A.L., Malvezzi M., Carioli G., et al. Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017 // Clinical Gastroenterology and Hepatology. 2016. Vol. 14, N 10. doi: 10.1016/j.cgh.2016.05.034

[5] Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery. 2005;138(1):8–13. doi: 10.1016/j.surg.2005.05.001

[6] Bassi C., Dervenis C., Butturini G., et al. Postoperative pancreatic fistula: An international study group (ISGPF) definition // Surgery. 2005. Vol. 138, N 1. P. 8–13. doi: 10.1016/j.surg.2005.05.001

[7] Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery (United States). 2017;161(3). doi: 10.1016/j.surg.2016.11.014

[8] Bassi C., Marchegiani G., Dervenis C., et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After // Surgery (United States). 2017. Vol. 161, N 3. doi: 10.1016/j.surg.2016.11.014

[9] Kabanov MYu, Sementsov KV, Yakovleva DM, Alekseev VV. The problem of development pancreatic fistula in patients undergoing pancreaticoduodenal resection. Bulletin Of Pirogov National Medical & Surgical Center. 2017;12(2). EDN: YTQHHV

[10] Кабанов М.Ю., Семенцов К.В., Яковлева Д.М., Алексеев В.В. Состояние проблемы развития панкреатической фистулы у пациентов, перенесших панкреатодуоденальную резекцию // Вестник Национального медико-хирургического Центра им. Н. И. Пирогова. 2017. Т. 12, № 2. EDN: YTQHHV

[11] Kleeff J, Diener M, Z’graggen K, et al. Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Annals of surgery. 2007;245(4):573–582. doi: 10.1097/01.SLA.0000251438.43135.FB

[12] Kleeff J., Diener M., Z’graggen K., et al. Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases // Annals of surgery. 2007. Vol. 245, N 4. P. 573–582. doi: 10.1097/01.SLA.0000251438.43135.FB

[13] Watanabe Y, Nishihara K, Matsumoto S, et al. Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review. Surgery Today. 2017;47(5). doi: 10.1007/s00595-016-1426-1

[14] Watanabe Y., Nishihara K., Matsumoto S., et al. Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review // Surgery Today. 2017. Vol. 47, N 5. doi: 10.1007/s00595-016-1426-1

[15] Büchler MW, Werner J, Weitz J. R0 in pancreatic cancer surgery: surgery, pathology, biology, or definition matters. Annals of surgery. 2010;251(6):1011–1012. doi: 10.1097/SLA.0B013E3181E07DAD

[16] Büchler M.W., Werner J., Weitz J. R0 in pancreatic cancer surgery: surgery, pathology, biology, or definition matters? // Annals of surgery. 2010. Vol. 251, N 6. P. 1011–1012. doi: 10.1097/SLA.0B013E3181E07DAD

[17] Büchler MW, Esposito I, Grenacher L, et al. Precancerous Lesions and Carcinoma of the Pancreas. Viszeralmedizin. 2015;31(1):53–57. doi: 10.1159/000375245

[18] Büchler M.W., Esposito I., Grenacher L., et al. Precancerous Lesions and Carcinoma of the Pancreas // Viszeralmedizin. 2015. Vol. 31, N 1. P. 53–57. doi: 10.1159/000375245

[19] McEvoy SH, Lavelle LP, Hoare SM, et al. Pancreaticoduodenectomy: Expected post-operative anatomy and complications. British Journal of Radiology. 2014;87(1041). doi: 10.1259/bjr.20140050

[20] McEvoy S.H., Lavelle L.P., Hoare S.M., et al. Pancreaticoduodenectomy: Expected post-operative anatomy and complications // British Journal of Radiology. 2014. Vol. 87, N 1041. doi: 10.1259/bjr.20140050

[21] Peng YP, Zhu XL, Yin LD, et al. Risk factors of postoperative pancreatic fistula in patients after distal pancreatectomy: a systematic review and meta-analysis. Scientific reports. 2017;7(1). doi: 10.1038/S41598-017-00311-8

[22] Peng Y.P., Zhu X.L., Yin L.D., et al. Risk factors of postoperative pancreatic fistula in patients after distal pancreatectomy: a systematic review and meta-analysis // Scientific reports. 2017. Vol. 7, N 1. doi: 10.1038/S41598-017-00311-8

[23] Lowy AM, Lee JE, Pisters PWT, et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Annals of Surgery. 1997;226(5). doi: 10.1097/00000658-199711000-00008

[24] Lowy A.M., Lee J.E., Pisters P.W.T., et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease // Annals of Surgery. 1997. Vol. 226, N 5. doi: 10.1097/00000658-199711000-00008

[25] Pugalenthi A, Protic M, Gonen M, et al. Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Journal of Surgical Oncology. 2016;113(2). doi: 10.1002/jso.24125

[26] Pugalenthi A., Protic M., Gonen M., et al. Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma // Journal of Surgical Oncology. 2016. Vol. 113, N 2. doi: 10.1002/jso.24125

[27] Kriger AG, Kubyshkin VA, Karmazanovskiĭ GG, et al. The postoperative pancreatitis after the pancreatic surgery. Pirogov Russian Journal Of Surgery. 2012;(4):14–19.

[28] Кригер А.Г., Кубышкин В.А., Карамазовский Г.Г., и др. Послеоперационный панкреатит при хирургических вмешательствах на поджелудочной железе // Хирургия. Журнал им. Н.И. Пирогова. 2012. № 4. С. 14–19. EDN: PEJWJZ

[29] Ramacciato G., Mercantini P., Petrucciani N., et al. Risk factors of pancreatic fistula after pancreaticoduodenectomy: A collective review. American Surgeon. 2011;77(3):257–269

[30] Ramacciato G., Mercantini P., Petrucciani N., et al. Risk factors of pancreatic fistula after pancreaticoduodenectomy: A collective review // American Surgeon. 2011. Vol. 77, N 3. P. 257–269.

[31] Rajarathinam G, Kannan DG, Vimalraj V, et al. Post pancreaticoduodenectomy haemorrhage: Outcome prediction based on new ISGPS Clinical severity grading. HPB: the official journal of the International Hepato Pancreato Biliary Association. 2008;10(5). doi: 10.1080/13651820802247086

[32] Rajarathinam G., Kannan D.G., Vimalraj V., et al. Post pancreaticoduodenectomy haemorrhage: Outcome prediction based on new ISGPS Clinical severity grading // HPB : the official journal of the International Hepato Pancreato Biliary Association. 2008. Vol. 10, N 5. doi: 10.1080/13651820802247086

[33] Chen H, Wang Y, Wang C, et al. The effect of perioperative of dexamethasone on postoperative complications after pancreaticoduodenectomy (PANDEX): a study protocol for a pragmatic multicenter randomized controlled trial. Trials. 2023;24(1). doi: 10.1186/S13063-023-07571-Y

[34] Chen H., Wang Y., Wang C., et al. The effect of perioperative of dexamethasone on postoperative complications after pancreaticoduodenectomy (PANDEX): a study protocol for a pragmatic multicenter randomized controlled trial // Trials. 2023. Vol. 24, N 1. doi: 10.1186/S13063-023-07571-Y

[35] Maehira H, Iida H, Mori H, et al. Computed Tomography Enhancement Pattern of the Pancreatic Parenchyma Predicts Postoperative Pancreatic Fistula after Pancreaticoduodenectomy. Pancreas. 2019;48(2). doi: 10.1097/MPA.0000000000001229

[36] Maehira H., Iida H., Mori H., et al. Computed Tomography Enhancement Pattern of the Pancreatic Parenchyma Predicts Postoperative Pancreatic Fistula after Pancreaticoduodenectomy // Pancreas. 2019. Vol. 48, N 2. doi: 10.1097/MPA.0000000000001229

[37] Sugimoto M, Takahashi S, Kobayashi T, et al. Pancreatic perfusion data and post-pancreaticoduodenectomy outcomes. The Journal of surgical research. 2015;194(2):441–449. doi: 10.1016/J.JSS.2014.11.046

[38] Sugimoto M., Takahashi S., Kobayashi T., et al. Pancreatic perfusion data and post-pancreaticoduodenectomy outcomes // The Journal of surgical research. 2015. Vol. 194, N 2. P. 441–449. doi: 10.1016/J.JSS.2014.11.046

[39] Oneil MacHado N. Pancreatic fistula after pancreatectomy: Definitions, risk factors, preventive measures, and management — Review. International Journal of Surgical Oncology. 2012;2012:10. doi: 10.1155/2012/602478

[40] Oneil MacHado N. Pancreatic fistula after pancreatectomy: Definitions, risk factors, preventive measures, and management — Review // International Journal of Surgical Oncology. 2012. Vol. 2012. P. 10. doi: 10.1155/2012/602478

[41] Sahakyan MA, Stepanyan SA, Gabrielyan AM, et al. Risk factors of pancreatic fistula following pancreatoduodenectomy. The New Armenian Medical Journal. 2015;9(4):95–101.

[42] Sahakyan M.A., Stepanyan S.A., Gabrielyan A.M., et al. Risk factors of pancreatic fistula following pancreatoduodenectomy // The New Armenian Medical Journal. 2015. Vol. 9, N 4. P. 95–101.

[43] Le Bian AZ, Fuks D, Montali F, et al. Predicting the Severity of Pancreatic Fistula after Pancreaticoduodenectomy: Overweight and Blood Loss as Independent Risk Factors: Retrospective Analysis of 277 Patients. Surgical Infections. 2019;20(6). doi: 10.1089/sur.2019.027

[44] Le Bian A.Z., Fuks D., Montali F., et al. Predicting the Severity of Pancreatic Fistula after Pancreaticoduodenectomy: Overweight and Blood Loss as Independent Risk Factors: Retrospective Analysis of 277 Patients // Surgical Infections. 2019. Vol. 20, N 6. doi: 10.1089/sur.2019.027

[45] Callery MP, Pratt WB, Kent TS, et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. Journal of the American College of Surgeons. 2013;216(1):1–14. doi: 10.1016/J.JAMCOLLSURG.2012.09.002

[46] Callery M.P., Pratt W.B., Kent T.S., et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy // Journal of the American College of Surgeons. 2013. Vol. 216, N 1. P. 1–14. doi: 10.1016/J.JAMCOLLSURG.2012.09.002

[47] Miller BC, Christein JD, Behrman SW, et al. A Multi-Institutional External Validation of the Fistula Risk Score for Pancreatoduodenectomy. Journal of Gastrointestinal Surgery. 2014;18(1). doi: 10.1007/s11605-013-2337-8

[48] Miller B.C., Christein J.D., Behrman S.W., et al. A Multi-Institutional External Validation of the Fistula Risk Score for Pancreatoduodenectomy // Journal of Gastrointestinal Surgery. 2014. Vol. 18, N 1. doi: 10.1007/s11605-013-2337-8

[49] Khatkov IE, Domrachev SA, Tsvirkun VV, et al. Prediction of postpancreatoduodenectomy pancreatic fistula with the use of computer tomography. Medical Visualization. 2019;23(1):19–27. doi: 10.24835/1607-0763-2019-1-19-27

[50] Хатьков И.Е., Домрачев С.А., Цвиркун В.В., и др. Прогнозирование панкреатической фистулы после панкреатодуоденальной резекции с помощью компьютерной томографии // Медицинская визуализация. 2019. Т. 23, № 1. С. 19–27. doi: 10.24835/1607-0763-2019-1-19-27

[51] Lin JW, Cameron JL, Yeo CJ, et al. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. Journal of Gastrointestinal Surgery. 2004;8(8). doi: 10.1016/j.gassur.2004.09.044

[52] Lin J.W., Cameron J.L., Yeo C.J., et al. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula // Journal of Gastrointestinal Surgery. 2004. Vol. 8, N 8. doi: 10.1016/j.gassur.2004.09.044

[53] Vallance AE, Young AL, Macutkiewicz C, et al. Calculating the risk of a pancreatic fistula after a pancreaticoduodenectomy: A systematic review. HPB: the official journal of the International Hepato Pancreato Biliary Association. 2015;17(11). doi: 10.1111/hpb.12503

[54] Vallance A.E., Young A.L., Macutkiewicz C., et al. Calculating the risk of a pancreatic fistula after a pancreaticoduodenectomy: A systematic review // HPB: the official journal of the International Hepato Pancreato Biliary Association. 2015. Vol. 17, N 11. doi: 10.1111/hpb.12503

[55] Drozdov ES, Topolnitskiy EB, Klokov SS, Dibina TV. Pancreatic fistula risk assessment after distal pancreatectomy: a retrospective controlled study. Kuban Scientific Medical Bulletin. 2021;28(2):33–45. EDN: EELLHM doi: 10.25207/1608-6228-2021-28-2-33-45

[56] Дроздов Е.С., Топольницкий Е.Б., Клоков С.С., Дибина Т.В. Прогнозирование риска развития послеоперационной панкреатической фистулы у пациентов, перенесших дистальную резекцию поджелудочной железы: ретроспективное контролируемое исследование // Кубанский научный медицинский вестник. 2021. Т. 28, № 2. С. 33–45. EDN: EELLHM doi: 10.25207/1608-6228-2021-28-2-33-45

[57] Waugh JM, Clagett OT. Resection of the duodenum and head of the pancreas for carcinoma; an analysis of thirty cases. Surgery. 1946;20:224-232.

[58] Waugh J.M., Clagett O.T. Resection of the duodenum and head of the pancreas for carcinoma; an analysis of thirty cases // Surgery. 1946. Vol. 20. P. 224-232.

[59] Sikora S.S., Posner M.C. Management of the pancreatic stump following pancreaticoduodenectomy. The British journal of surgery. 1995;82(12):1590–1597. doi: 10.1002/bjs.1800821205

[60] Sikora S.S., Posner M.C. Management of the pancreatic stump following pancreaticoduodenectomy // The British journal of surgery. 1995. Vol. 82, N 12. P. 1590–1597. doi: 10.1002/bjs.1800821205

[61] Sohn T. A., Yeo C. J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2000;(6):567–579. doi: 10.1016/s1091-255x(00)80105-5

[62] Sohn T. A., Yeo C. J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators // Journal of gastrointestinal surgery. 2000. Vol. 4, N 6. P. 567–579. doi: 10.1016/s1091-255x(00)80105-5

[63] Zhou Y., Zhou Q., Li Z., Chen R. Internal pancreatic duct stent does not decrease pancreatic fistula rate after pancreatic resection: A meta-analysis. American Journal of Surgery. 2013;205(6):715–725. doi: 10.1016/j.amjsurg.2012.07.039

[64] Zhou Y., Zhou Q., Li Z., Chen R. Internal pancreatic duct stent does not decrease pancreatic fistula rate after pancreatic resection: A meta-analysis // American Journal of Surgery. 2013. Vol. 205, N 6. P. 715–725. doi: 10.1016/j.amjsurg.2012.07.039

[65] El Nakeeb A, El Shobary M, El Dosoky M, et al. Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience). Hepato-Gastroenterology. 2014;61(133):1426–1438.

[66] El Nakeeb A., El Shobary M., El Dosoky M., et al. Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience) // Hepato-Gastroenterology. 2014. Vol. 61, N 133. P. 1426–1438.

[67] Poon R, Fan ST, Lo C.M, et al. External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: A prospective randomized trial. Annals of Surgery. 2007;246(3):425–435. doi: 10.1097/SLA.0b013e3181492c28

[68] Poon R., Fan S.T., Lo C.M., et al. External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: A prospective randomized trial // Annals of Surgery. 2007. Vol. 246, N 3. P. 425–435. doi: 10.1097/SLA.0b013e3181492c28

[69] Smyrniotis V, Arkadopoulos N, Kyriazi MA, et al. Does internal stenting of the pancreaticojejunostomy improve outcomes after pancreatoduodenectomy? A prospective study. Langenbeck’s Archives of Surgery. 2010;395(3):195–200. doi: 10.1007/s00423-009-0585-6

[70] Smyrniotis V., Arkadopoulos N., Kyriazi M.A., et al. Does internal stenting of the pancreaticojejunostomy improve outcomes after pancreatoduodenectomy? A prospective study // Langenbeck’s Archives of Surgery. 2010. Vol. 395, N 3. P. 195–200. doi: 10.1007/s00423-009-0585-6

[71] Mikhailov MM. Diagnosis and treatment of distal pancreatic tumors [dissertation]. Moscow; 2001. (In Russ).

[72] Михайлов М.М. Диагностика и лечение опухолей дистального отдела поджелудочной железы : дис. ... канд. мед. наук. Москва, 2001.

[73] Mayo WJ. The Surgery of the Pancreas. Annals of surgery. 1913;58(2):145–150. doi: 10.1097/00000658-191308000-00001

[74] Mayo W.J. The Surgery of the Pancreas // Annals of surgery. 1913. Vol. 58, N 2. P. 145–150. doi: 10.1097/00000658-191308000-00001

[75] Knaebel HP, Diener MK, Wente MN, et al. Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. British Journal of Surgery. 2005;92(5):539–546. doi: 10.1002/bjs.5000

[76] Knaebel H.P., Diener M.K., Wente M.N., et al. Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy // British Journal of Surgery. 2005. Vol. 92, N 5. P. 539–546. doi: 10.1002/bjs.5000

[77] Lillemoe KD, Kaushal S, Cameron JL, et al. Distal pancreatectomy: Indications and outcomes in 235 patients. Annals of Surgery. 1999;229(5):693. doi: 10.1097/00000658-199905000-00012

[78] Lillemoe K.D., Kaushal S., Cameron J.L., et al. Distal pancreatectomy: Indications and outcomes in 235 patients // Annals of Surgery. 1999. Vol. 229, N 5. P. 693. doi: 10.1097/00000658-199905000-00012

[79] Cuschieri A. Laparoscopic surgery of the pancreas. Journal of the Royal College of Surgeons of Edinburgh. 1994;39(3):178–184.

[80] Cuschieri A. Laparoscopic surgery of the pancreas // Journal of the Royal College of Surgeons of Edinburgh. 1994. Vol. 39, N 3. P. 178–184.

[81] Van Hilst J, De Rooij T, Klompmaker S, et al. Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study. Annals of surgery. 2019;269(1):10–17. doi: 10.1097/SLA.0000000000002561

[82] Van Hilst J., De Rooij T., Klompmaker S., et al. Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study // Annals of surgery. 2019. Vol. 269, N 1. P. 10–17. doi: 10.1097/SLA.0000000000002561

[83] Loos M, Strobel O, Legominski M, et al. Postoperative pancreatic fistula: Microbial growth determines outcome. Surgery (United States). 2018;164(6). doi: 10.1016/j.surg.2018.07.024

[84] Loos M., Strobel O., Legominski M., et al. Postoperative pancreatic fistula: Microbial growth determines outcome // Surgery (United States). 2018. Vol. 164, N 6. doi: 10.1016/j.surg.2018.07.024

[85] Adiamah A, Arif Z, Berti F, et al. The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials. World journal of surgery. 2019;43(7):1788–1801. doi: 10.1007/S00268-019-04956-6

[86] Adiamah A., Arif Z., Berti F., et al. The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials // World journal of surgery. 2019. Vol. 43, N 7. P. 1788–1801. doi: 10.1007/S00268-019-04956-6

[87] Cheng Y, Ye M, Xiong X, et al. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. The Cochrane database of systematic reviews. 2016;2(2). doi: 10.1002/14651858.CD009621.PUB2

[88] Cheng Y., Ye M., Xiong X., et al. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery // The Cochrane database of systematic reviews. 2016. Vol. 2, N 2. doi: 10.1002/14651858.CD009621.PUB2

[89] Seetharam P, Rodrigues G.S. Postoperative Pancreatic Fistula: A Surgeon’s Nightmare! An Insight with a Detailed Literature Review. JOP. 2015;(2):115-124. doi: 10.6092/1590-8577/2937

[90] Seetharam P., Rodrigues G.S. Postoperative Pancreatic Fistula: A Surgeon’s Nightmare! An Insight with a Detailed Literature Review // JOP. 2015. Vol. 16, N 2. P. 115–124. doi: 10.6092/1590-8577/2937

[91] Ishikawa O, Ohigashi H, Imaoka S, et al. Concomitant Benefit of Preoperative Irradiation in Preventing Pancreas Fistula Formation After Pancreatoduodenectomy. Archives of Surgery. 1991;126(7). doi: 10.1001/archsurg.1991.01410310095014

[92] Ishikawa O., Ohigashi H., Imaoka S., et al. Concomitant Benefit of Preoperative Irradiation in Preventing Pancreas Fistula Formation After Pancreatoduodenectomy // Archives of Surgery. 1991. Vol. 126, N 7. doi: 10.1001/archsurg.1991.01410310095014

[93] Yang DJ, Xiong JJ, Lu HM, et al. The oncological safety in minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Scientific reports. 2019;9(1). doi: 10.1038/S41598-018-37617-0

[94] Yang D.J., Xiong J.J., Lu H.M., et al. The oncological safety in minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis // Scientific reports. 2019. Vol. 9, N 1. doi: 10.1038/S41598-018-37617-0

[95] El Nakeeb A, El Sorogy M, Ezzat H, et al. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors. Hepatobiliary and Pancreatic Diseases International. 2018;17(5). doi: 10.1016/j.hbpd.2018.08.004

[96] El Nakeeb A., El Sorogy M., Ezzat H., et al. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors // Hepatobiliary and Pancreatic Diseases International. 2018. Vol. 17, N 5. doi: 10.1016/j.hbpd.2018.08.004

[97] Shah MH, Goldner WS, Benson AB, et al. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2021;19(7). doi: 10.6004/jnccn.2021.0032

[98] Shah M.H., Goldner W.S., Benson A.B., et al. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology // Journal of the National Comprehensive Cancer Network. 2021. Vol. 19, N 7. doi: 10.6004/jnccn.2021.0032

[99] Wang X, Tan CL, Zhang H, et al. Short-term outcomes and risk factors for pancreatic fistula after pancreatic enucleation: A single-center experience of 142 patients. Journal of Surgical Oncology. 2018;117(2):182–190. doi: 10.1002/jso.24804

[100] Wang X., Tan C.L., Zhang H., et al. Short-term outcomes and risk factors for pancreatic fistula after pancreatic enucleation: A single-center experience of 142 patients // Journal of Surgical Oncology. 2018. Vol. 117, N 2. P. 182–190. doi: 10.1002/jso.24804

[101] Serrano PE, Kim D, Kim PT, et al. Effect of pancreatic fistula on recurrence and long-term prognosis of periampullary adenocarcinomas after pancreaticoduodenectomy. American Surgeon. 2016;82(12). doi: 10.1177/000313481608201225

[102] Serrano P.E., Kim D., Kim P.T., et al. Effect of pancreatic fistula on recurrence and long-term prognosis of periampullary adenocarcinomas after pancreaticoduodenectomy // American Surgeon. 2016. Vol. 82, N 12. doi: 10.1177/000313481608201225

[103] Grego A, Friziero A, Serafini S, et al. Does pancreatic fistula affect long-term survival after resection for pancreatic cancer? A systematic review and meta-analysis. Cancers. 2021;13(22). doi: 10.3390/cancers13225803

[104] Grego A., Friziero A., Serafini S., et al. Does pancreatic fistula affect long-term survival after resection for pancreatic cancer? A systematic review and meta-analysis // Cancers. 2021. Vol. 13, N 22. doi: 10.3390/cancers13225803

[105] Uchida Y, Masui T, Nagai K, et al. Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadjuvant chemoradiotherapy: A retrospective analysis. Surgical Oncology. 2020;35(1). doi: 10.1016/j.suronc.2020.10.010

[106] Uchida Y., Masui T., Nagai K., et al. Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadjuvant chemoradiotherapy: A retrospective analysis // Surgical Oncology. 2020. Vol. 35, N 1. doi: 10.1016/j.suronc.2020.10.010

[107] Wang H, Shao Z, Guo SW, et al. Analysis of prognostic factors for hyperamylasemia following pancreaticoduodenectomy. Zhonghua wai ke za zhi [Chinese journal of surgery]. 2019;57(7). doi: 10.3760/cma.j.issn.0529-5815.2019.07.011

[108] Wang H., Shao Z., Guo S.W., et al. Analysis of prognostic factors for hyperamylasemia following pancreaticoduodenectomy // Zhonghua wai ke za zhi [Chinese journal of surgery]. 2019. Vol. 57, N 7. doi: 10.3760/cma.j.issn.0529-5815.2019.07.011

[109] Watanabe Y, Nishihara K, Matsumoto S, et al. Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review. Surgery today. 2017;47(5):555–567. doi: 10.1007/s00595-016-1426-1

[110] Watanabe Y., Nishihara K., Matsumoto S., et al. Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review // Surgery today. 2017. Vol. 47, N. 5. P. 555–567. doi: 10.1007/s00595-016-1426-1

[111] Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. The British journal of surgery. 2008;95(5):627–635. doi: 10.1002/BJS.6051

[112] Fischer L., Kleeff J., Esposito I., et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas // The British journal of surgery. 2008. Vol. 95, N 5. P. 627–635. doi: 10.1002/BJS.6051

[113] Bilimoria KY, Talamonti MS, Tomlinson JS, et al. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Annals of surgery. 2008;247(3):490–500. doi: 10.1097/SLA.0b013e31815b9cae

[114] Bilimoria K.Y., Talamonti M.S., Tomlinson J. S., et al. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients // Annals of surgery. 2008. Vol. 247, N. 3. P. 490–500. doi: 10.1097/SLA.0b013e31815b9cae

[115] Xu J, Ji SR, Zhang B, et al. Strategies for pancreatic anastomosis after pancreaticoduodenectomy: What really matters? Hepatobiliary & pancreatic diseases international: HBPD INT. 2018;17(1):22–26. doi: 10.1016/j.hbpd.2018.01.012

[116] Xu J., Ji S.R., Zhang B., et al. Strategies for pancreatic anastomosis after pancreaticoduodenectomy: What really matters? // Hepatobiliary & pancreatic diseases international: HBPD INT. 2018. Vol. 17, N.1. P. 22–26. doi: 10.1016/j.hbpd.2018.01.012

[117] Isaji S, Mizuno S, Windsor JA, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology. 2018;18(1). doi: 10.1016/j.pan.2017.11.011

[118] Isaji S., Mizuno S., Windsor J.A., et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017 // Pancreatology. 2018. Vol. 18, N 1. doi: 10.1016/j.pan.2017.11.011

[119] Gerstle JT, Kauffman GJ, Koltun WA. The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies. Journal of the American College of Surgeons. 1995;180(4):427–432.

[120] Gerstle J.T., Kauffman G.J., Koltun W.A. The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies // Journal of the American College of Surgeons. 1995. Vol. 180, N 4. P. 427–432.

RIGHTS & PERMISSIONS

Eco-Vector